Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May;49(5):443-450.
doi: 10.1007/s00595-018-1753-5. Epub 2019 Jan 7.

SOCS3 overexpression in T cells ameliorates chronic airway obstruction in a murine heterotopic tracheal transplantation model

Affiliations
Free article

SOCS3 overexpression in T cells ameliorates chronic airway obstruction in a murine heterotopic tracheal transplantation model

Kumi Mesaki et al. Surg Today. 2019 May.
Free article

Abstract

Purpose: Suppressor of cytokine signaling-3 (SOCS3) is a negative feedback inhibitor of cytokine signaling with T-cell-mediated immunosuppressive effects on obliterative bronchiolitis (OB). In this study, we aimed to investigate the impact of T-cell-specific overexpression of SOCS3 using a murine heterotopic tracheal transplantation (HTT) model.

Methods: Tracheal allografts from BALB/c mice were subcutaneously transplanted into wild-type C57BL/6J (B6; WT) mice and SOCS3 transgenic B6 (SOCS3TG) mice. Tracheal allografts were analyzed by immunohistochemistry and quantitative polymerase chain reaction assays at days 7 and 21.

Results: At day 21, allografts in SOCS3TG mice showed significant amelioration of airway obstruction and epithelial loss compared with allografts in WT mice. The intragraft expression of IFN-γ and CXCL10 was suppressed, while that of IL-4 was enhanced in SOCS3TG mice at day 7. The T-bet levels were lower in SOCS3TG allografts than in WT allografts at day 7.

Conclusion: We revealed that the overexpression of SOCS3 in T cells effectively ameliorates OB development in a murine HTT model by inhibiting the Th1 phenotype in the early phase. Our results suggest that the regulation of the T-cell response, through the modulation of SOCS expression, has potential as a new therapeutic strategy for chronic lung allograft dysfunction.

Keywords: CLAD; Lung transplantation; OB; SOCS3; Th1.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Am J Transplant. 2012 Feb;12(2):438-46 - PubMed
    1. Diabetologia. 2008 Oct;51(10):1873-82 - PubMed
    1. PLoS One. 2013 Jul 30;8(7):e70236 - PubMed
    1. Semin Respir Crit Care Med. 2013 Jun;34(3):336-51 - PubMed
    1. Am J Respir Cell Mol Biol. 1998 Sep;19(3):379-86 - PubMed

MeSH terms

Substances